MCL-1 inhibitors, fast-lane development of a new class of anti-cancer agents
2020 · Journal of Hematology & Oncology · 163 citations
https://doi.org/10.1186/s13045-020-01007-9
A
Arnold Bolomsky
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
102
Papers
939
Citations
17
h-index
22
i10-index
Arnold Bolomsky is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Multiple Myeloma Research and Treatments & Protein Degradation and Inhibitors & HIV/AIDS drug development and treatment. The author has an h-index of 17, co-authored 87 publications.
ORCID: 0000-0002-1585-5429Papers by this author
worksInsulin like growth factor binding protein 7 (IGFBP7) expression is linked to poor prognosis but may protect from bone disease in multiple myeloma
2015 · Journal of Hematology & Oncology · 30 citations
https://doi.org/10.1186/s13045-014-0105-1
Oncogenic RAS commandeers amino acid sensing machinery to aberrantly activate mTORC1 in multiple myeloma
2022 · Nature Communications · 23 citations
https://doi.org/10.1038/s41467-022-33142-x
OA-38 Targeting SWI/SNF Extinguishes IRF4 Expression in Multiple Myeloma
2024 · Clinical Lymphoma Myeloma & Leukemia · 0 citations
https://doi.org/10.1016/s2152-2650(24)01879-2
Supplementary Tables S1-S12 from Targeting N-linked Glycosylation for the Therapy of Aggressive Lymphomas
2024 · 0 citations
https://doi.org/10.1158/2159-8290.27025571
Supplementary Tables S1-S12 from Targeting N-linked Glycosylation for the Therapy of Aggressive Lymphomas
2024 · 0 citations
https://doi.org/10.1158/2159-8290.27025571.v1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat